There is an increasing number of promising studiesthat focus on using various approaches to NETs degradation in oncology,including the use of DNase I. The application of DNase I implies that both NETsand cfDNA will undergo degradation, which is expected to ensure a moreefficient inhibitory effect on cancer. This evidence concerns the gene DNASE1 and cancer.